Johnson & Johnson Raises Talc Settlement Offer to $9B, Moves Closer to Settlement Victory

Johnson & Johnson (NYSE:JNJ) has reportedly increased its settlement offer by $1 billion, now totaling about $9 billion, to address claims that its talc baby powder caused gynecological cancer.

This move has secured preliminary support from Allen Smith, a prominent tort lawyer representing around 12,000 claimants, marking a significant shift in the ongoing legal battle.

Also Read: Court Orders Johnson & Johnson To Compensate Auris Health Shareholders $1B.

Smith, who filed the first talc-related lawsuit against Johnson & Johnson in 2009, has been a staunch opponent ...